1. Home
  2. APEI vs ERAS Comparison

APEI vs ERAS Comparison

Compare APEI & ERAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APEI
  • ERAS
  • Stock Information
  • Founded
  • APEI 1991
  • ERAS 2018
  • Country
  • APEI United States
  • ERAS United States
  • Employees
  • APEI N/A
  • ERAS N/A
  • Industry
  • APEI Other Consumer Services
  • ERAS Biotechnology: Pharmaceutical Preparations
  • Sector
  • APEI Consumer Discretionary
  • ERAS Health Care
  • Exchange
  • APEI Nasdaq
  • ERAS Nasdaq
  • Market Cap
  • APEI 396.4M
  • ERAS 448.1M
  • IPO Year
  • APEI 2007
  • ERAS 2021
  • Fundamental
  • Price
  • APEI $21.26
  • ERAS $1.41
  • Analyst Decision
  • APEI Buy
  • ERAS Strong Buy
  • Analyst Count
  • APEI 4
  • ERAS 5
  • Target Price
  • APEI $21.00
  • ERAS $5.70
  • AVG Volume (30 Days)
  • APEI 79.6K
  • ERAS 1.2M
  • Earning Date
  • APEI 03-04-2025
  • ERAS 03-26-2025
  • Dividend Yield
  • APEI N/A
  • ERAS N/A
  • EPS Growth
  • APEI N/A
  • ERAS N/A
  • EPS
  • APEI 0.56
  • ERAS N/A
  • Revenue
  • APEI $613,253,000.00
  • ERAS N/A
  • Revenue This Year
  • APEI $5.70
  • ERAS N/A
  • Revenue Next Year
  • APEI $4.20
  • ERAS N/A
  • P/E Ratio
  • APEI $40.47
  • ERAS N/A
  • Revenue Growth
  • APEI 2.18
  • ERAS N/A
  • 52 Week Low
  • APEI $10.30
  • ERAS $1.41
  • 52 Week High
  • APEI $23.84
  • ERAS $3.45
  • Technical
  • Relative Strength Index (RSI)
  • APEI 44.89
  • ERAS 25.44
  • Support Level
  • APEI $20.78
  • ERAS $1.52
  • Resistance Level
  • APEI $22.40
  • ERAS $1.76
  • Average True Range (ATR)
  • APEI 0.81
  • ERAS 0.13
  • MACD
  • APEI -0.07
  • ERAS 0.00
  • Stochastic Oscillator
  • APEI 21.62
  • ERAS 0.00

About APEI American Public Education Inc.

American Public Education Inc provides online and on-campus postsecondary education including various undergraduate and graduate degree programs. The fields of study include business administration, health science, technology, criminal justice, education, liberal arts, national security, military studies, intelligence, and homeland security. There are three reporting segments: the American Public University segment which is the key revenue generator; the Rasmussen University Segment and the Hondros College of Nursing segment. The revenue is generated from net course registrations and enrollment, tuition rate, net tuition, and other fees.

About ERAS Erasca Inc.

Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's pipeline includes; Naporafenib, a pan-RAF inhibitor with first-in-class potential in NRASm melanoma, RAS Q61X tissue agnostic solid tumors, and other RAS/MAPK pathway-driven tumors, and ERAS-007 (oral ERK1/2 inhibitor) and ERAS-601 (oral SHP2 inhibitor), which target downstream and upstream nodes, respectively, of the RAS/MAPK pathway.

Share on Social Networks: